The P/LP variants in the NBN gene were presented only by a deletion of five nucleotides, c.657_661del, which was found in BC patients and in controls (OR = 1.2 [95% CI: 0.3–4.8], p > 0.05). This evidence concerns the gene NBN and breast cancer.